(Q34788410)

4 August 2017

title

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers (English)

1 reference

4 August 2017

Makito Miyake

1

1 reference

4 August 2017

Adrienne Lawton

2

1 reference

4 August 2017

Steve Goodison

3

1 reference

4 August 2017

Virginia Urquidi

4

1 reference

4 August 2017

Evan Gomes-Giacoia

5

1 reference

4 August 2017

Ge Zhang

6

1 reference

4 August 2017

Shanti Ross

7

1 reference

4 August 2017

Jeongsoon Kim

8

1 reference

4 August 2017

Charles J Rosser

9

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

4 August 2017

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

page(s)

322

1 reference

4 August 2017

cites work

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

The expression and role of CXC chemokines in colorectal cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

NF-kappa B genes have a major role in inflammatory breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Molecular evidence supporting field effect in urothelial carcinogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

ONCOMINE: a cancer microarray database and integrated data-mining platform

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Role of CXCL1 in tumorigenesis of melanoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Chemokines in cutaneous wound healing.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3708804

Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-322

Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-322

The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-322

CXC chemokines located in the 4q21 region are up-regulated in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-322

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-322

Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-322

21 January 2018

1 reference

12 December 2020

Melanoma growth stimulatory activity in primary malignant melanoma: prognostic significance

1 reference

12 December 2020

Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix

1 reference

12 December 2020

Gene Expression Signatures Predict Outcome in Non-Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

1 reference

12 December 2020

Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-13-322

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference